Loading organizations...
§ Private Profile · Toronto, ON, Canada
Immune cell therapy focused on next-generation cancer treatments.
Notch Therapeutics has raised $85.0M across 1 funding round.
Notch Therapeutics has raised $85.0M in total across 1 funding round.
Notch Therapeutics has raised $85.0M across 1 funding round. Most recently, it raised $85.0M Series A in February 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 15, 2021 | $85M Series A | — | David Chang, Amplitude Ventures, Casdin Capital, Ccrm Enterprises Holdings, EcoR1 Capital, Lumira Ventures, Samsara BioCapital | Announced |
Notch Therapeutics has raised $85.0M in total across 1 funding round.
Notch Therapeutics's investors include David Chang, Amplitude Ventures, Casdin Capital, CCRM Enterprises Holdings, EcoR1 Capital, Lumira Ventures, Samsara BioCapital.